SEC Form 4 · accession 0001387131-19-001333
Tonix Pharmaceuticals Holding Corp. · TNXP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James Treco
Director
Period of report
Feb 14, 2019
Accepted (ET)
Feb 19, 2019 · 4:54 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001430306
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionF1 | $1.86 | Feb 14, 2019 | A | 10,000 | A | — | Feb 14, 2029 | Common Stock | 10,000 | 10,000 | D |
Explanation of responses
- F1The option was granted on February 14, 2019 pursuant to the Issuer's 2018 Equity Incentive Plan and vests on the date of the Issuer's 2019 annual meeting of shareholders.